OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
13.32
+0.15 (1.14%)
Jan 6, 2026, 4:00 PM EST - Market closed
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $248.29 million as of January 6, 2026. Its market cap has increased by 157.83% in one year.
Market Cap
248.29M
Enterprise Value
257.38M
1-Year Change
157.83%
Ranking
Category
Stock Price
$13.32
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $248.29M, an increase of 626.00%. That is a compound annual growth rate of 30.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 245.50M | 7.44% |
| Dec 31, 2025 | 228.50M | 155.31% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
| Jun 22, 2018 | 34.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.48B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |